Japan Aims To Support Innovation But Local Pharma Wants More
This article was originally published in PharmAsia News
While Japan's government is declaring its support for innovation in the life sciences sector, the domestic pharma industry is saying it is being hard hit by other policies encouraging generics and would like to see the implementation of more positive policies.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.